Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 13

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 13
---
 Company’s
independent registered public accounting firm was approved by the Company’s Audit Committee and the Company’s Board of Directors
as being in the best interests of the Company.

<div align='center'>S-4</div>

THE OFFERING

| Common Stock Offered by us:                                         |     | Shares of our common stock having an aggregate price of up to $20,000,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Manner of offering:                                                 |     | “At the market offering” that may be made from time to time through our Sales Agent. The Sales Agent will make all sales using commercially reasonable efforts consistent with its normal trading and sales practices and applicable laws and regulations, on mutually agreeable terms between the Sales Agent and us. The sales of shares of our common stock under this prospectus supplement, if any, may be made directly on the Nasdaq Capital Market, or through a market maker other than on an exchange. With our prior written consent, sales may also be made in negotiated transactions and/or any other method permitted by law. See “Plan of Distribution” on page S-10 of this prospectus supplement. |
| Common Stock to be outstanding immediately after this offering (1): |     | 16,830,721 shares, assuming the issuance of 9,569,377, assuming a sale price of $2.09 per share, based on the last reported sale price of our common stock of $2.09 on Nasdaq on November 14, 2025. The actual number of shares issued will vary depending on the sales price at which shares may be sold from time to time during this offering.                                                                                                                                                                                                                                                                                                                                                                   |
| Use of proceeds:                                                    |     | We intend to use the net proceeds from these sales, if any, general                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Risk Factors:                                                       |     | Your investment in our securities involves substantial risks. You corporate purposes, which may include, without limitation, investing in or acquiring companies that are synergistic with or complementary to our business and working capital. See “Use of Proceeds” on page S-8 of this prospectus supplement. should consider the “Risk Factors” and the “Cautionary Note Regarding Forward-Looking Statements” included and incorporated by reference in this prospectus supplement and the accompanying base prospectus, including the risk factors incorporated by reference from our filings with the SEC.                                                                                                  |
| Nasdaq Capital Market Symbol:                                       |     | “HCTI”